Search research articles
Contact Us
Filters
Showing results (61-70 of 137) with videos related to
Page
of 14
Sort By:
Clinical Therapeutics
|
March 2, 2006
An integrated analysis of thirteen trials summarizing the long-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy
Bernard Goffe, Kim Papp, David Gratton, et al.
Journal of the American Academy of Dermatology
|
February 21, 2006
Relapse, rebound, and psoriasis adverse events: an advisory group report
Wayne Carey, Scott Glazer, Alice B Gottlieb, et al.
Cutis
|
September 1, 2011
An open-label, multicenter study of the efficacy and safety of an AM/PM treatment regimen with clobetasol propionate spray 0.05% and calcitriol ointment 3 microg/g in the management of plaque psoriasis
Alan Menter, Howard Sofen, Stacy Smith, et al.
Journal of Cutaneous Medicine and Surgery
|
January 8, 2010
Update on alefacept safety
Denise Wexler, Gordon Searles, Ian Landells, et al.
Cutis
|
November 24, 2011
An open-label, multicenter study of the efficacy and safety of a weekday/weekend treatment regimen with calcitriol ointment 3 microg/g and clobetasol propionate spray 0.05% in the management of plaque psoriasis
Charles P Hudson, Steven Kempers, Alan Menter, et al.
Rheumatology (Oxford, England)
|
October 25, 2022
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 1 study
Lars Erik Kristensen, Mauro Keiserman, Kim Papp, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
August 31, 2017
Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome
Hermenio Lima, Melinda Gooderham, Jan Dutz, et al.
Journal of Cutaneous Medicine and Surgery
|
November 22, 2017
Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition
Robert Bissonnette, Marc Bourcier, Melinda Gooderham, et al.
Journal of Cutaneous Medicine and Surgery
|
May 4, 2005
Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004
Lyn Guenther, Richard G Langley, Neil H Shear, et al.
Journal of Cutaneous Medicine and Surgery
|
September 17, 2016
Review of Systemic Treatment Options for Adult Atopic Dermatitis
Melinda Gooderham, Charles W Lynde, Kim Papp, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 137) with videos related to
Sort By:
Page
of 14
Clinical Therapeutics
|
March 2, 2006
An integrated analysis of thirteen trials summarizing the long-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy
Bernard Goffe, Kim Papp, David Gratton, et al.
Journal of the American Academy of Dermatology
|
February 21, 2006
Relapse, rebound, and psoriasis adverse events: an advisory group report
Wayne Carey, Scott Glazer, Alice B Gottlieb, et al.
Cutis
|
September 1, 2011
An open-label, multicenter study of the efficacy and safety of an AM/PM treatment regimen with clobetasol propionate spray 0.05% and calcitriol ointment 3 microg/g in the management of plaque psoriasis
Alan Menter, Howard Sofen, Stacy Smith, et al.
Journal of Cutaneous Medicine and Surgery
|
January 8, 2010
Update on alefacept safety
Denise Wexler, Gordon Searles, Ian Landells, et al.
Cutis
|
November 24, 2011
An open-label, multicenter study of the efficacy and safety of a weekday/weekend treatment regimen with calcitriol ointment 3 microg/g and clobetasol propionate spray 0.05% in the management of plaque psoriasis
Charles P Hudson, Steven Kempers, Alan Menter, et al.
Rheumatology (Oxford, England)
|
October 25, 2022
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 1 study
Lars Erik Kristensen, Mauro Keiserman, Kim Papp, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
August 31, 2017
Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome
Hermenio Lima, Melinda Gooderham, Jan Dutz, et al.
Journal of Cutaneous Medicine and Surgery
|
November 22, 2017
Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition
Robert Bissonnette, Marc Bourcier, Melinda Gooderham, et al.
Journal of Cutaneous Medicine and Surgery
|
May 4, 2005
Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004
Lyn Guenther, Richard G Langley, Neil H Shear, et al.
Journal of Cutaneous Medicine and Surgery
|
September 17, 2016
Review of Systemic Treatment Options for Adult Atopic Dermatitis
Melinda Gooderham, Charles W Lynde, Kim Papp, et al.
Page
of 14